OPTIONAL Bevacizumab until PROGRESSION GOG Statistical Manual
{"Image DocumentName": "OPTIONAL Bevacizumab until PROGRESSION GOG Statistical Manual", "Image ImageDescription": "Different taxol IV schedules  OPTIONAL Bevacizumab during Treatment and as Maintenance. Maintenance  Paclitaxel 80 mg/m2 IV days 1, 8,15. Carboplatin AUC 6 IV day 1.  Bevacizumab 15 mg/kg IV on day 1. R. A. N. D. O. M. I. Z. E. Previously untreated epithelial ovarian, primary peritoneal, or fallopian tube cancer. Stage II. III optimal suboptimal. Stage IV. OPTIONAL Bevacizumab until PROGRESSION. Set A1 \u2013 Content Slide. Paclitaxel 175 mg/m2 IV days 1. Carboplatin AUC 6 IV day 1.  Bevacizumab 15 mg/kg IV on day 1. GOG Statistical Manual.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}